Formula: | C21H22N4O3S |
Molecular Weight: | 410.50 |
Rotatable Bond Donors: | 5 |
clogP: | 2.61 |
Topological Polar Surface Area: | 75.51 |
Lipinski's RO5: | MW: 410.50 HBA: 7 HBD: 0 RB: 5 LogP: 2.61 |
Rule of Three: | MW: 410.50 HBA: 7 HBD: 0 RB: 5 LogP: 2.61 |
|
ECBD ID | Similarity | Structure | SDF |
---|
ECBD ID | Similarity | Structure | SDF | |
---|---|---|---|---|
EOS760 | 0.7 | EOS760 RDKit 3D 29 32 0 0 0 0 0 0 0 0999 V2000 8.5492 -0.8734 -2.6434 C 0 0 0 0 0 0 0 0 0 0 0 0 8.4130 -1.3900 -1.3253 O 0 0 0 0 0 0 0 0 0 0 0 0 7.2720 -0.9356 -0.7262 C 0 0 0 0 0 0 0 0 0 0 0 0 6.3714 -0.0518 -1.3185 C 0 0 0 0 0 0 0 0 0 0 0 0 5.2327 0.3572 -0.6258 C 0 0 0 0 0 0 0 0 0 0 0 0 4.9915 -0.1134 0.6632 C 0 0 0 0 0 0 0 0 0 0 0 0 3.8740 0.2661 1.4159 N 0 0 0 0 0 0 0 0 0 0 0 0 2.8689 1.1296 1.0175 C 0 0 0 0 0 0 0 0 0 0 0 0 2.7770 1.7222 -0.0516 O 0 0 0 0 0 0 0 0 0 0 0 0 1.8558 1.2739 2.1185 C 0 0 0 0 0 0 0 0 0 0 0 0 0.5651 0.7635 1.7181 N 0 0 0 0 0 0 0 0 0 0 0 0 0.2761 -0.5396 1.4419 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.0064 -0.7012 1.2047 N 0 0 0 0 0 0 0 0 0 0 0 0 -1.5598 0.5665 1.3597 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.2617 0.9049 1.1917 S 0 0 0 0 0 0 0 0 0 0 0 0 -3.3110 2.2587 0.6783 O 0 0 0 0 0 0 0 0 0 0 0 0 -3.8081 0.5662 2.4916 O 0 0 0 0 0 0 0 0 0 0 0 0 -3.9068 -0.1676 0.0340 N 0 0 0 0 0 0 0 0 0 0 0 0 -3.7325 -1.6078 0.4051 C 0 0 0 0 0 0 0 0 0 0 0 0 -5.0690 -2.3159 0.1390 C 0 0 0 0 0 0 0 0 0 0 0 0 -5.9658 -1.1923 -0.2491 C 0 0 0 0 0 0 0 0 0 0 0 0 -7.3091 -1.2646 -0.5681 C 0 0 0 0 0 0 0 0 0 0 0 0 -7.9633 -0.0845 -0.9235 C 0 0 0 0 0 0 0 0 0 0 0 0 -7.2733 1.1345 -0.9596 C 0 0 0 0 0 0 0 0 0 0 0 0 -5.9177 1.1943 -0.6388 C 0 0 0 0 0 0 0 0 0 0 0 0 -5.2894 0.0188 -0.2644 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.5907 1.4875 1.7063 C 0 0 0 0 0 0 0 0 0 0 0 0 5.8904 -0.9978 1.2558 C 0 0 0 0 0 0 0 0 0 0 0 0 7.0275 -1.4084 0.5625 C 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 0 2 3 1 0 3 4 2 0 4 5 1 0 5 6 2 0 6 7 1 0 7 8 1 0 8 9 2 0 8 10 1 0 10 11 1 0 11 12 1 0 12 13 2 0 13 14 1 0 14 15 1 0 15 16 2 0 15 17 2 0 15 18 1 0 18 19 1 0 19 20 1 0 20 21 1 0 21 22 2 0 22 23 1 0 23 24 2 0 24 25 1 0 25 26 2 0 14 27 2 0 6 28 1 0 28 29 2 0 29 3 1 0 27 11 1 0 26 18 1 0 26 21 1 0 M END $$$$ |
Name | Assay stage | Target | Activity |
---|---|---|---|
GPR35 antagonism | primary assay | G-protein coupled receptor 35 | inactive |